Literature DB >> 26238794

Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.

Koichi Watashi1, Takaji Wakita1.   

Abstract

Entry of hepatitis B (HBV) and hepatitis D viruses (HDV) into a host cell represents the initial step of infection. This process requires multiple steps, including the low-affinity attachment of the virus to the cell surface, followed by high-affinity attachment to specific receptor(s), and subsequent endocytosis-mediated internalization. Within the viral envelope, the preS1 region is involved in receptor binding. Recently, sodium taurocholate cotransporting polypeptide (NTCP) has been identified as an entry receptor of HBV and HDV by affinity purification using a preS1 peptide. NTCP is mainly or exclusively expressed in the liver, and this membrane protein is at least one of the factors determining the narrow species specificity and hepatotropism of HBV and HDV. However, there are likely other factors that mediate the species and tissue tropism of HBV. This review summarizes the current understanding of the mechanisms of HBV/HDV entry.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238794      PMCID: PMC4526719          DOI: 10.1101/cshperspect.a021378

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  65 in total

1.  HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.

Authors:  Hanjie Li; Qiuyu Zhuang; Yuze Wang; Tianying Zhang; Jinghua Zhao; Yali Zhang; Junfang Zhang; Yi Lin; Quan Yuan; Ningshao Xia; Jiahuai Han
Journal:  Cell Mol Immunol       Date:  2014-02-10       Impact factor: 11.530

2.  Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.

Authors:  Dieter Glebe; Stephan Urban; Eva V Knoop; Nilgün Cag; Peter Krass; Stefanie Grün; Aiste Bulavaite; Kestutis Sasnauskas; Wolfram H Gerlich
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition.

Authors:  Azeneth Barrera; Bernadette Guerra; Lena Notvall; Robert E Lanford
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.

Authors:  Darong Yang; Chaohui Zuo; Xiaohong Wang; Xianghe Meng; Binbin Xue; Nianli Liu; Rong Yu; Yuwen Qin; Yimin Gao; Qiuping Wang; Jun Hu; Ling Wang; Zebin Zhou; Bing Liu; Deming Tan; Yang Guan; Haizhen Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

5.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

7.  Role of glycosaminoglycans for binding and infection of hepatitis B virus.

Authors:  Corinna M Leistner; Stefanie Gruen-Bernhard; Dieter Glebe
Journal:  Cell Microbiol       Date:  2008-01       Impact factor: 3.715

8.  Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.

Authors:  V Bruss; J Hagelstein; E Gerhardt; P R Galle
Journal:  Virology       Date:  1996-04-15       Impact factor: 3.616

9.  Structural basis of the alternating-access mechanism in a bile acid transporter.

Authors:  Xiaoming Zhou; Elena J Levin; Yaping Pan; Jason G McCoy; Ruchika Sharma; Brian Kloss; Renato Bruni; Matthias Quick; Ming Zhou
Journal:  Nature       Date:  2013-12-08       Impact factor: 49.962

10.  Proteoglycans act as cellular hepatitis delta virus attachment receptors.

Authors:  Oscar Lamas Longarela; Tobias T Schmidt; Katrin Schöneweis; Raffaella Romeo; Heiner Wedemeyer; Stephan Urban; Andreas Schulze
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more
  19 in total

1.  Structure of the bile acid transporter and HBV receptor NTCP.

Authors:  Jinta Asami; Kanako Terakado Kimura; Yoko Fujita-Fujiharu; Hanako Ishida; Zhikuan Zhang; Yayoi Nomura; Kehong Liu; Tomoko Uemura; Yumi Sato; Masatsugu Ono; Masaki Yamamoto; Takeshi Noda; Hideki Shigematsu; David Drew; So Iwata; Toshiyuki Shimizu; Norimichi Nomura; Umeharu Ohto
Journal:  Nature       Date:  2022-05-17       Impact factor: 49.962

Review 2.  The use of humanized mice for studies of viral pathogenesis and immunity.

Authors:  Florian Douam; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2018-03-28       Impact factor: 7.090

3.  The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.

Authors:  Masashi Iwamoto; Wakana Saso; Kazane Nishioka; Hirofumi Ohashi; Ryuichi Sugiyama; Akihide Ryo; Mio Ohki; Ji-Hye Yun; Sam-Yong Park; Takayuki Ohshima; Ryosuke Suzuki; Hideki Aizaki; Masamichi Muramatsu; Tetsuro Matano; Shingo Iwami; Camille Sureau; Takaji Wakita; Koichi Watashi
Journal:  J Biol Chem       Date:  2019-12-12       Impact factor: 5.157

Review 4.  Engineering Hepadnaviruses as Reporter-Expressing Vectors: Recent Progress and Future Perspectives.

Authors:  Weiya Bai; Xiaoxian Cui; Youhua Xie; Jing Liu
Journal:  Viruses       Date:  2016-05-10       Impact factor: 5.048

Review 5.  Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule.

Authors:  Qiushi Liu; Masaharu Somiya; Shun'ichi Kuroda
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

6.  Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus.

Authors:  Gansukh Choijilsuren; Ren-Shiang Jhou; Shu-Fan Chou; Ching-Jen Chang; Hwai-I Yang; Yang-Yuan Chen; Wan-Long Chuang; Ming-Lung Yu; Chiaho Shih
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

7.  Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication.

Authors:  Masashi Iwamoto; Dawei Cai; Masaya Sugiyama; Ryosuke Suzuki; Hideki Aizaki; Akihide Ryo; Naoko Ohtani; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita; Haitao Guo; Koichi Watashi
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

8.  Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma.

Authors:  Peng Wang; Ruidong Mo; Rongtao Lai; Yumin Xu; Jie Lu; Gangde Zhao; Yuhan Liu; Zhujun Cao; Xiaolin Wang; Ziqiang Li; Lanyi Lin; Huijuan Zhou; Wei Cai; Hui Wang; Shisan Bao; Xiaogang Xiang; Qing Xie
Journal:  Oncotarget       Date:  2017-10-31

9.  Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection.

Authors:  Antonia Alexandra Evripioti; Ana Maria Ortega-Prieto; Jessica Katy Skelton; Quentin Bazot; Marcus Dorner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

10.  Go go gadget glycoprotein!: HSV-1 draws on its sizeable glycoprotein tool kit to customize its diverse entry routes.

Authors:  Adam T Hilterbrand; Ekaterina E Heldwein
Journal:  PLoS Pathog       Date:  2019-05-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.